Anixa Biosciences (ANIX) Competitors $2.94 -0.05 (-1.51%) As of 01:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANIX vs. VIGL, AQST, OLMA, RCKT, FULC, ABEO, ALDX, ATXS, BNTC, and ADCTShould you be buying Anixa Biosciences stock or one of its competitors? The main competitors of Anixa Biosciences include Vigil Neuroscience (VIGL), Aquestive Therapeutics (AQST), Olema Pharmaceuticals (OLMA), Rocket Pharmaceuticals (RCKT), Fulcrum Therapeutics (FULC), Abeona Therapeutics (ABEO), Aldeyra Therapeutics (ALDX), Astria Therapeutics (ATXS), Benitec Biopharma (BNTC), and ADC Therapeutics (ADCT). These companies are all part of the "pharmaceutical products" industry. Anixa Biosciences vs. Its Competitors Vigil Neuroscience Aquestive Therapeutics Olema Pharmaceuticals Rocket Pharmaceuticals Fulcrum Therapeutics Abeona Therapeutics Aldeyra Therapeutics Astria Therapeutics Benitec Biopharma ADC Therapeutics Anixa Biosciences (NASDAQ:ANIX) and Vigil Neuroscience (NASDAQ:VIGL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings. Does the media refer more to ANIX or VIGL? In the previous week, Anixa Biosciences had 2 more articles in the media than Vigil Neuroscience. MarketBeat recorded 2 mentions for Anixa Biosciences and 0 mentions for Vigil Neuroscience. Anixa Biosciences' average media sentiment score of 0.00 equaled Vigil Neuroscience'saverage media sentiment score. Company Overall Sentiment Anixa Biosciences Neutral Vigil Neuroscience Neutral Do institutionals & insiders hold more shares of ANIX or VIGL? 29.1% of Anixa Biosciences shares are owned by institutional investors. Comparatively, 83.6% of Vigil Neuroscience shares are owned by institutional investors. 25.3% of Anixa Biosciences shares are owned by company insiders. Comparatively, 18.0% of Vigil Neuroscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, ANIX or VIGL? Anixa Biosciences has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, Vigil Neuroscience has a beta of 3.33, indicating that its stock price is 233% more volatile than the S&P 500. Is ANIX or VIGL more profitable? Anixa Biosciences' return on equity of -68.17% beat Vigil Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Anixa BiosciencesN/A -68.17% -60.38% Vigil Neuroscience N/A -111.70%-74.67% Do analysts rate ANIX or VIGL? Anixa Biosciences presently has a consensus price target of $9.00, suggesting a potential upside of 205.60%. Vigil Neuroscience has a consensus price target of $10.80, suggesting a potential upside of 34.16%. Given Anixa Biosciences' stronger consensus rating and higher probable upside, research analysts clearly believe Anixa Biosciences is more favorable than Vigil Neuroscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anixa Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Vigil Neuroscience 0 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger earnings & valuation, ANIX or VIGL? Anixa Biosciences is trading at a lower price-to-earnings ratio than Vigil Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnixa BiosciencesN/AN/A-$12.55M-$0.38-7.75Vigil NeuroscienceN/AN/A-$84.26M-$2.05-3.93 SummaryAnixa Biosciences beats Vigil Neuroscience on 9 of the 12 factors compared between the two stocks. Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIX vs. The Competition Export to ExcelMetricAnixa BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$94.86M$3.09B$5.75B$9.85BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-7.7520.8882.7926.52Price / SalesN/A369.93499.49162.43Price / CashN/A43.5325.7028.92Price / Book4.998.0310.786.50Net Income-$12.55M-$53.35M$3.28B$266.34M7 Day Performance-2.16%-1.05%-0.42%-1.25%1 Month Performance-9.66%5.84%6.47%3.30%1 Year Performance-15.13%10.76%49.47%23.59% Anixa Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIXAnixa Biosciences2.5232 of 5 stars$2.95-1.5%$9.00+205.6%-7.4%$94.86MN/A-7.755Upcoming EarningsVIGLVigil Neuroscience1.4752 of 5 stars$8.05flat$10.80+34.2%N/A$383.91MN/A-3.9340AQSTAquestive Therapeutics1.7704 of 5 stars$3.77-1.6%$10.14+169.0%-5.7%$375.96M$57.56M-5.39160Analyst UpgradeGap UpOLMAOlema Pharmaceuticals2.0792 of 5 stars$5.46-1.1%$24.00+339.6%-44.6%$374.74MN/A-2.7670News CoverageAnalyst ForecastRCKTRocket Pharmaceuticals4.8977 of 5 stars$3.28-2.1%$16.73+410.2%-81.6%$353.92MN/A-1.31240Positive NewsFULCFulcrum Therapeutics1.0062 of 5 stars$6.48-2.6%$7.57+16.8%-19.5%$350.51M$80M-5.31100News CoveragePositive NewsABEOAbeona Therapeutics4.3687 of 5 stars$6.83-0.7%$19.50+185.5%+27.3%$350.23M$3.50M9.7690ALDXAldeyra Therapeutics2.4906 of 5 stars$5.84-0.3%$9.50+62.7%+0.7%$349.79MN/A-6.8710News CoveragePositive NewsATXSAstria Therapeutics2.3259 of 5 stars$6.18-5.4%$29.00+369.3%-39.0%$348.77MN/A-3.0730News CoverageBNTCBenitec Biopharma1.6749 of 5 stars$13.24+1.6%$26.00+96.4%+54.9%$347.56M$80K-8.7720News CoverageGap DownADCTADC Therapeutics2.7354 of 5 stars$3.08-5.4%$7.75+152.0%+20.3%$345.37M$70.84M-1.96310Short Interest ↓ Related Companies and Tools Related Companies Vigil Neuroscience Alternatives Aquestive Therapeutics Alternatives Olema Pharmaceuticals Alternatives Rocket Pharmaceuticals Alternatives Fulcrum Therapeutics Alternatives Abeona Therapeutics Alternatives Aldeyra Therapeutics Alternatives Astria Therapeutics Alternatives Benitec Biopharma Alternatives ADC Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored“Shadow Group” in Washington, DC Could Crash MarketNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Anixa Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ANIX Stock Alerts